Automated Insulin Delivery
Automated insulin delivery (AID) is a diabetes therapy that combines a continuous glucose monitor, an insulin pump, and a control algorithm to adjust insulin delivery in response to measured glucose.
Automated insulin delivery (AID) is a diabetes therapy that combines a continuous glucose monitor, an insulin pump, and a control algorithm to adjust insulin delivery in response to measured glucose. By automating aspects of insulin dosing, AID is intended to support glycemic control while limiting exposure to hypoglycemia. Systems may use tubed or disposable tubeless insulin pumps and may incorporate adaptive algorithms, including technologies studied with Control-IQ and Omnipod 5 Automated Insulin Delivery System. AID is used particularly in type 1 diabetes, where its effects are assessed using measures such as hemoglobin A1c, time-in-range 70–180 mg/dL, mean glucose, and severe hypoglycemia.
Current research examines AID in children and adolescents as well as adults, including comparisons with Multiple Daily Injections and sensor-augmented pump therapy. Studies also evaluate postprandial control according to meal composition, treatment satisfaction, diabetes distress, device adoption and discontinuation, and diabetes-related acute care utilization. Emerging applications include people with cystic fibrosis-related diabetes and advanced chronic kidney disease, populations in which feasibility, safety, insulin dose, and durability of glycemic benefit require specific evaluation.
Where the papers sit
10 papers from the last 6 months study Automated Insulin Delivery directly · updated from PubMed 7 Nov 2026
Study type 0 clinical trials · 7 observational · 3 human data
Themes 3 themes
-
Glycemic Outcomes in Type 1 Diabetes
Time in range, time below range, and hemoglobin A1c remain the core measures of AID effectiveness in type 1 diabetes. Outcomes are increasingly examined in relation to meal composition, menstrual-cycle changes, age, and diabetes distress. Real-world studies of tubeless, Control-IQ, and open-source systems support benefit across varied users, but performance still depends on daily physiological and behavioral context. The field is moving toward more individualized assessment of postprandial and recurrent glycemic patterns.
5 papers · 50%
-
AID Adoption and Acute Care
Broader use of AID is being examined across cystic fibrosis-related diabetes, type 1 diabetes, and acute diabetes care. Adoption studies focus on why adults start or discontinue devices, while clinical evaluations track hypoglycemia and diabetes-related acute-care utilization. Tubeless systems are being assessed in routine practice rather than only controlled settings. The main open question is whether wider uptake reduces the burden of acute events across different diabetes populations.
3 papers · 30%
-
Youth Glycemic Outcomes
AID research in youth is moving toward identifying which children achieve better glycemic trajectories after initiation. Multicenter analyses extend this question to preschool-age users, where insulin needs, safety, and device uptake require particular attention. Regression models use baseline characteristics, insulin use, and hemoglobin A1c to estimate differences in response. The evidence remains focused on prediction and characterization rather than a settled set of determinants.
2 papers · 20%
Papers
The 10 papers from the last 6 months that study Automated Insulin Delivery directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.
By theme
Glycemic Outcomes in Type 1 Diabetes (5)
- Menstrual cycle-related variations in insulin requirements and glycemic control during automated insulin delivery in adolescents with type 1 diabetes. Journal of pediatric endocrinology & metabolism : JPEM · 28 Aug 2026 PMID 42665003
- Real-World Glycemic Outcomes of Open-Source Automated Insulin Delivery During 12 Months Among People With Type 1 Diabetes Across Age Groups. Diabetes, obesity & metabolism · 27 Aug 2026 PMID 42660857
- Comparison of AID users and non-users regarding glycemic control and diabetes distress: A mixed-methods study. PloS one · 24 Jul 2026 PMID 42497120
- Real-World Effectiveness and Safety of a Tubeless Automated Insulin Delivery System With an Adaptive Control Algorithm (APGO) in Children and Adolescents With Type 1 Diabetes: A Multicentre Observational Study. Diabetes, obesity & metabolism · 23 Jul 2026 PMID 42488981
- Postprandial Glycemic Control With Automated Insulin Delivery With Control-IQ Technology: The Impact of Meal Composition. Diabetes, obesity & metabolism · 20 Jul 2026 PMID 42476949
AID Adoption and Acute Care (3)
- Diabetes-related acute care utilization following initiation of automated insulin delivery (AID): A comparison of a disposable tubeless AID system and durable tubed systems. Journal of managed care & specialty pharmacy · 9 Jul 2026 PMID 42424112
- Advancing Cystic Fibrosis-Related Diabetes Care With Automated Insulin Delivery Systems. Clinical therapeutics · 16 Jun 2026 PMID 42303551
- Adopters and discontinuers: Mapping the diabetes device adoption journeys of adults with type 1 diabetes after continuous glucose monitoring uptake. Patient education and counseling · 28 May 2026 PMID 42208318
Youth Glycemic Outcomes (2)
- What Makes the Difference? Predicting Glycemic Trajectories Following Initiation of Automated Insulin Delivery Systems in Youth With Type 1 Diabetes. Diabetes care · 16 Jul 2026 PMID 42461939
- Automated Insulin Delivery Use Among Preschool-Age Children With Type 1 Diabetes: A T1D Exchange Multicenter Analysis. Journal of diabetes science and technology · 23 Jun 2026 PMID 42335144
By study type
Observational studies and case reports (7)
- Menstrual cycle-related variations in insulin requirements and glycemic control during automated insulin delivery in adolescents with type 1 diabetes. Journal of pediatric endocrinology & metabolism : JPEM · 28 Aug 2026 PMID 42665003
- Real-World Effectiveness and Safety of a Tubeless Automated Insulin Delivery System With an Adaptive Control Algorithm (APGO) in Children and Adolescents With Type 1 Diabetes: A Multicentre Observational Study. Diabetes, obesity & metabolism · 23 Jul 2026 PMID 42488981
- Postprandial Glycemic Control With Automated Insulin Delivery With Control-IQ Technology: The Impact of Meal Composition. Diabetes, obesity & metabolism · 20 Jul 2026 PMID 42476949
- Diabetes-related acute care utilization following initiation of automated insulin delivery (AID): A comparison of a disposable tubeless AID system and durable tubed systems. Journal of managed care & specialty pharmacy · 9 Jul 2026 PMID 42424112
- Automated Insulin Delivery Use Among Preschool-Age Children With Type 1 Diabetes: A T1D Exchange Multicenter Analysis. Journal of diabetes science and technology · 23 Jun 2026 PMID 42335144
- Advancing Cystic Fibrosis-Related Diabetes Care With Automated Insulin Delivery Systems. Clinical therapeutics · 16 Jun 2026 PMID 42303551
- Adopters and discontinuers: Mapping the diabetes device adoption journeys of adults with type 1 diabetes after continuous glucose monitoring uptake. Patient education and counseling · 28 May 2026 PMID 42208318
Human data, design not indexed (3)
- Real-World Glycemic Outcomes of Open-Source Automated Insulin Delivery During 12 Months Among People With Type 1 Diabetes Across Age Groups. Diabetes, obesity & metabolism · 27 Aug 2026 PMID 42660857
- Comparison of AID users and non-users regarding glycemic control and diabetes distress: A mixed-methods study. PloS one · 24 Jul 2026 PMID 42497120
- What Makes the Difference? Predicting Glycemic Trajectories Following Initiation of Automated Insulin Delivery Systems in Youth With Type 1 Diabetes. Diabetes care · 16 Jul 2026 PMID 42461939
Written from 10 PubMed abstracts, each one listed by PMID above. Published: 2026-10-02. Drafted by language models from published abstracts; not medical advice.